Health Catalyst Inc (HCAT) returns
Health Catalyst returns over 5 years
$1,000 invested in Health Catalyst five years ago was worth $32.11 at the close on October 30, 2026, with dividends reinvested: an average return of -49.7% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -2.3% | — | $976.88 | -0.9% |
| 3 months | -18.8% | — | $812.50 | +2.1% |
| Year to date | -29.3% | — | $707.11 | +11.7% |
| 1 year | -48.5% | — | $515.24 | +12.4% |
| 3 years | -76.5% | -38.3% | $235.05 | +88.5% |
| 5 years | -96.8% | -49.7% | $32.11 | +76.0% |
Health Catalyst return by calendar year
| Year | HCAT | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -29.3% | +11.7% | -41.0% |
| 2025 | -66.2% | +17.7% | -83.9% |
| 2024 | -23.7% | +24.9% | -48.5% |
| 2023 | -12.9% | +26.2% | -39.1% |
| 2022 | -73.2% | -18.2% | -55.0% |
| 2021 | -9.0% | +28.7% | -37.7% |
| 2020 | +25.4% | +18.4% | +7.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: HCAT financials
No forecast, no recommendation. This page describes Health Catalyst Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.